Tilray Brands (TLRY) Net Margin Growth (3y) (2023 - 2026)
Tilray Brands (TLRY) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 513.31 Mn | 278.68 Mn | 90.52 Mn | -10,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -10,691.00 |
| Feb 28, 2026 | 80,911.00 |
| Nov 30, 2025 | 3,901.00 |
| Aug 31, 2025 | 4,367.00 |
| May 31, 2025 | -16,065.00 |
| Feb 28, 2025 | -46,169.00 |
| Nov 30, 2024 | -4,416.00 |
| Aug 31, 2024 | 327.00 |
| May 31, 2024 | -18,499.00 |
| Feb 29, 2024 | -8,803.00 |
| Nov 30, 2023 | 4,511.00 |
| Aug 31, 2023 | -1,306.00 |
| May 31, 2023 | 11,938.00 |